ESMO Real World Data and Digital Oncology
Издатель: Elsevier · ISSN 2949-8201 · 95 статей
- 347P Beyond chatbots: Grounding generative AI in mechanistic simulation and historical trial data for reliable oncology clinical decision support
- 348P A multi-large language model framework for multidimensional oncology treatment market Mapping: First-line metastatic squamous NSCLC
- 349P National authorisation and reimbursement status as inputs to LLM evidence synthesis in oncology: A deterministic, GRADE-informed pipeline
- 350P Control-arm appropriateness in breast cancer randomized trials: An LLM framework integrating trial data and oncologist posts on X
- 351P Beyond prompt engineering: Automated training of LLM skills for false assumptions in cancer communication
- 352P Evaluating LLMs for surgical video analysis: A zero-shot benchmark
- 353P The preservation gap: The NAT-clinical framework for governing clinical large language models across updates
- 354P Accountability by design in clinical oncology: A governance framework for safe large language model deployment
- 355P TRUST-AI-TB: European consensus on trustworthy artificial intelligence in thoracic oncology multidisciplinary tumor boards
- 356P Where Latin America set the limits of generative AI in clinical oncology: A continent-wide modified Delphi consensus (COMPASS)
- 357P Beyond accuracy: A GenAI implementation readiness framework for oncology
- 358P SCREEN-AI India: A structured pre-deployment framework for evaluating oncology AI tools in low and middle-income countries
- 359P DAISY: Guidelines for preparing AI-ready CT scans
- 360P Mapping priorities and controversies in digital health: Findings from an expert and stakeholder consensus conference
- 361P Payer and HTA acceptability of synthetic control arms for single-arm trials: A five-country study
- 362P A digital twin framework for synthetic control arm generation: A proof-of-concept assessment of the phase III ECHO trial intervention cohort
- 363P Generation of synthetic patient survival data from trial-level metadata using machine learning
- 364P Beyond treatment assignment: Evaluating longitudinal oncology strategies using real-world cancer registry data
- 365P Population impact of national DPYD commissioning on severe fluoropyrimidine-related harm in England: Interrupted time-series and self-controlled case-series analyses using linked routine data
- 366P Patient perspectives on artificial intelligence in cancer care and needs for education and transparency
- 367P Trust in artificial intelligence for chemotherapy decision-making: A scenario-based cross-sectional surveyinformed by previous cancer treatment history
- 368P Large language model-assisted writing in oncology: A bibliometric analysis of signaling word trends across ESMO conferences
- 369P Artificial intelligence content at the ESMO Congress 2021–2025: Prevalence, application domains, validation level and geography
- 370P A multi-dimension audit of generative AI oncology trials: Implications for design and reporting
- 371eP From multiparametric MRI to precision segmentation: An automated framework for accurate brain tumor delineation
- 372eP A single multimodal survival model robust to missing modalities: Intermediate fusion of foundation model embeddings in a pan-cancer TCGA cohort
- 373eP Mapping global authorship networks in phase 3 cancer trials Using the Geographic Complexity Index (GCI)
- 374eP Conflict of interest reporting for editors and boards of oncology journals: A cross-sectional analysis
- Artificial intelligence in oncology: from isolated task-specific tools toward integrated decision support systems
- Reply to “Beyond pairwise comparisons of androgen receptor signaling inhibitors in nonmetastatic castration-resistant prostate cancer”